Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T14:57:20.129Z.
Calculation as of: 2026-10-06T14:57:20.129Z.
Quote observation: 2026-10-06T14:55:28.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 12822cf5764c24a0ef00c724f2a960962c8ab94682162e48d6be38065653aaef
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
ImmunityBio, Inc.
Market Cap
$10.36B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.25B
Operating Cash Flow Yield
8.88%
TTM Avg
6.86%
3Y Avg
5.22%
5Y Avg
4.52%
Market Cap
$10.23B
Operating Cash Flow Yield
7.39%
TTM Avg
5.81%
3Y Avg
4.85%
5Y Avg
4.30%
Market Cap
$10.07B
Operating Cash Flow Yield
6.04%
TTM Avg
5.15%
3Y Avg
4.87%
5Y Avg
5.29%
Market Cap
$10.06B
Operating Cash Flow Yield
3.63%
TTM Avg
3.71%
3Y Avg
4.53%
5Y Avg
6.94%
Market Cap
$10.67B
Operating Cash Flow Yield
16.88%
TTM Avg
16.24%
3Y Avg
14.28%
5Y Avg
12.88%
Market Cap
$9.96B
Operating Cash Flow Yield
4.95%
TTM Avg
6.18%
3Y Avg
5.41%
5Y Avg
4.43%
Market Cap
$10.86B
Operating Cash Flow Yield
9.51%
TTM Avg
6.32%
3Y Avg
4.63%
5Y Avg
4.42%
Market Cap
$10.99B
Operating Cash Flow Yield
7.80%
TTM Avg
7.76%
3Y Avg
4.61%
5Y Avg
3.23%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | $10.36B | N/A | N/A | N/A | N/A |
| Globus Medical, Inc. (GMED)vs › | $10.25B | 8.88% | 6.86% | 5.22% | 4.52% |
| Align Technology, Inc. (ALGN)vs › | $10.23B | 7.39% | 5.81% | 4.85% | 4.30% |
| The Ensign Group, Inc. (ENSG)vs › | $10.07B | 6.04% | 5.15% | 4.87% | 5.29% |
| Molina Healthcare, Inc. (MOH)vs › | $10.06B | 3.63% | 3.71% | 4.53% | 6.94% |
| Universal Health Services, Inc. (UHS)vs › | $10.67B | 16.88% | 16.24% | 14.28% | 12.88% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.96B | 4.95% | 6.18% | 5.41% | 4.43% |
| The Cooper Companies, Inc. (COO)vs › | $10.86B | 9.51% | 6.32% | 4.63% | 4.42% |
| BioMarin Pharmaceutical Inc. (BMRN)vs › | $10.99B | 7.80% | 7.76% | 4.61% | 3.23% |
| Henry Schein, Inc. (HSIC)vs › | $9.72B | 7.20% | 6.59% | 7.11% | 6.80% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
